CD4 and breast cancer: Furthermore, the HSPG syndecan-1 was shown to exert an immunomodulatory role on the polarization of CD4+ T helper (Th) subsets isolated from the tumor tissues of patients with inflammatory BC and non-inflammatory BC [217].